Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

US Patent 11359013 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HPV proteins, antibodies, and uses in managing abnormal epithelial cell growth2025
Ebola virus antibodies and binding agents derived therefrom2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Method of assessing the efficacy of a test agent for modulating programmed death2025
Outer semi join for disjunctive subquery unnesting2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Immune cells with DNMT3A gene modifications and methods related thereto2024
Methods for upregulating immune responses using combinations of anti-RGMb and an2024
Automatic partitioning of materialized views2024
KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof2024
Methods and compositions for treating diseases associated with exhausted T cells2024